Published in Am J Respir Crit Care Med on January 01, 1995
Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev (1999) 12.90
Retracted Immunopathology and immunogenetics of allergic bronchopulmonary aspergillosis. J Allergy (Cairo) (2011) 1.44
Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol (2011) 1.21
[Aspergillomas of the lung: report of 37 cases in Madagascar]. Pan Afr Med J (2011) 0.83
[Lung cavities, mycetomas and hemoptysis]. Wien Med Wochenschr (2007) 0.75
Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med (2009) 8.30
Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma. Thorax (1999) 4.11
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis (1985) 3.77
[Three patients with massive pulmonary embolism]. Ned Tijdschr Geneeskd (2001) 2.89
PC(20) adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than PC(20) methacholine. Am J Respir Crit Care Med (2001) 2.36
Corticosteroid-induced improvement in the PC20 of adenosine monophosphate is more closely associated with reduction in airway inflammation than improvement in the PC20 of methacholine. Am J Respir Crit Care Med (2001) 2.08
Catecholamine dependency in a polytrauma patient: relative adrenal insufficiency? Intensive Care Med (2000) 2.04
[The significance of elevated troponin levels in the absence of acute cardiac ischaemia]. Ned Tijdschr Geneeskd (2005) 2.03
Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax (2000) 2.02
Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J (1996) 1.93
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J (2007) 1.90
Allergen reduction measures in houses of allergic asthmatic patients: effects of air-cleaners and allergen-impermeable mattress covers. Eur Respir J (1997) 1.86
Detection of Aspergillus antigens associated with invasive infection. J Clin Microbiol (1990) 1.83
Condition on arrival of transferred critically ill patients. Neth J Med (2000) 1.67
Interleukin-4, interferon-gamma and interleukin-5 in peripheral blood of children with moderate atopic asthma. Clin Exp Allergy (1997) 1.65
Afut1, a retrotransposon-like element from Aspergillus fumigatus. Nucleic Acids Res (1996) 1.64
Comparison of restriction fragment length polymorphism, microsatellite length polymorphism, and random amplification of polymorphic DNA analyses for fingerprinting Aspergillus fumigatus isolates. J Clin Microbiol (2001) 1.64
Attenuated virulence of uridine-uracil auxotrophs of Aspergillus fumigatus. Infect Immun (1996) 1.60
Mediastinal emphysema complicating diabetic ketoacidosis: plea for conservative diagnostic approach. Neth J Med (2007) 1.55
Influence of in vivo prednisolone on increased in vitro O2- generation by neutrophils in emphysema. Eur Respir J (1993) 1.54
Nonspecific factors involved in attachment of entomopathogenic deuteromycetes to host insect cuticle. Appl Environ Microbiol (1988) 1.52
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors. Trop Med Int Health (2001) 1.51
[Orthopnea: not always of cardiac origin]. Ned Tijdschr Geneeskd (1999) 1.40
Chloroquine- and sulfadoxine-pyrimethamine-resistant Falciparum malaria in vivo - a pilot study in rural Zambia. Trop Med Int Health (2000) 1.39
Antileukoprotease: an endogenous protein in the innate mucosal defense against fungi. J Infect Dis (1997) 1.39
[CBO guideline 'Bacterial meningitis']. Ned Tijdschr Geneeskd (2001) 1.38
A 17-yr old boy with productive cough and progressive dyspnoea. Eur Respir J (2000) 1.37
Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease. Thorax (1999) 1.30
Measurement of plasma histamine by stable isotope dilution gas chromatography-mass spectrometry: methodology and normal values. Anal Biochem (1984) 1.28
Comparison of antibody measurements against Aspergillus fumigatus by means of double-diffusion and enzyme-linked immunosorbent assay (ELISA). J Allergy Clin Immunol (1983) 1.24
[Fulminant pneumococcal sepsis in two splenectomized patients]. Ned Tijdschr Geneeskd (2003) 1.23
Wood degradation by white rot fungi: cytochemical studies using lignin peroxidase-immunoglobulin-gold complexes. Appl Environ Microbiol (1987) 1.21
Putative virulence factors of Aspergillus fumigatus. Clin Exp Allergy (2000) 1.20
Characterization of obstructive airway disease in family members of probands with asthma. An algorithm for the diagnosis of asthma. Am J Respir Crit Care Med (1998) 1.17
Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms. J Infect Dis (1999) 1.16
Clinical effects of air cleaners in homes of asthmatic children sensitized to pet allergens. J Allergy Clin Immunol (1999) 1.16
IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J Immunol (1996) 1.16
Accuracy of eosinophils and eosinophil cationic protein to predict steroid improvement in asthma. Clin Exp Allergy (2002) 1.12
Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur Respir J (1998) 1.12
Review of fungus-induced asthmatic reactions. Am J Respir Crit Care Med (1995) 1.12
No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy (2006) 1.12
Optimization of skin testing. I. Choosing allergen concentrations and cutoff values by factorial design. Allergy (1993) 1.11
Evidence for a direct relationship between phosphoinositide metabolism and airway smooth muscle contraction induced by muscarinic agonists. Eur J Pharmacol (1988) 1.10
Immunomodulatory effects of macrolide antibiotics - part 1: biological mechanisms. Respiration (2010) 1.09
Secretory leukoprotease inhibitor: a native antimicrobial protein presenting a new therapeutic option? Thorax (1998) 1.09
Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism. Genes Immun (2006) 1.09
The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis (2012) 1.08
Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection. Antimicrob Agents Chemother (2010) 1.08
Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol Microbiol (1991) 1.08
[Relative adrenocortical insufficiency with sepsis, diagnosed and treated with hydrocortisone supplementation]. Ned Tijdschr Geneeskd (2001) 1.07
[Anaphylactic reactions following insect bites: clinical aspects, course and treatment]. Ned Tijdschr Geneeskd (1994) 1.07
Purification and characterization of an endo-1,3-beta-glucanase from Aspergillus fumigatus. Eur J Biochem (1997) 1.07
Sequential sampling of fungal air spores inside and outside the homes of mould-sensitive, asthmatic patients: a search for a relationship to obstructive reactions. Ann Allergy (1985) 1.07
Histopathology of experimental invasive pulmonary aspergillosis in rats: pathological comparison of pulmonary lesions induced by specific virulent factor deficient mutants. Microb Pathog (1999) 1.06
Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis. Clin Infect Dis (2009) 1.05
Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol (1999) 1.03
Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax (2002) 1.02
Specific serum immunopatterns in clinical phases of allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol (1992) 1.01
Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience. Eur Respir J (2011) 1.01
Interactions between inhalant allergen extracts and airway epithelial cells: effect on cytokine production and cell detachment. J Allergy Clin Immunol (1998) 1.01
Bronchial obstructive reactions after inhalation with endotoxin and precipitinogens of Haemophilus influenzae in patients with chronic non-specific lung disease. Clin Allergy (1982) 1.00
Partial inhibition of the early and late asthmatic response by a single dose of salmeterol. Am J Respir Crit Care Med (1994) 0.98
Seasonal variation in airway hyperresponsiveness and natural exposure to house dust mite allergens in patients with asthma. J Allergy Clin Immunol (1994) 0.97
Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts. Eur Respir J (1999) 0.97
The respiratory chain of Azotobacter vinelandii. I. Spectral properites of cytochrome d. Biochim Biophys Acta (1973) 0.96
Seasonal differences in airway hyperresponsiveness in asthmatic patients: relationship with allergen exposure and sensitization to house dust mites. Clin Exp Allergy (1997) 0.95
Resistance of activated human Th2 cells to NO-induced apoptosis is mediated by gamma-glutamyltranspeptidase. Int Immunol (2001) 0.94
Inhibition of PAF-induced expression of CD11b and shedding of L-selectin on human neutrophils and eosinophils by the type IV selective PDE inhibitor, rolipram. Eur Respir J (1997) 0.94
Allergen-induced recruitment of inflammatory cells in lavage 3 and 24 h after challenge in allergic asthmatic lungs. Chest (1993) 0.94
An 88-kilodalton antigen secreted by Aspergillus fumigatus. Infect Immun (1993) 0.94
Volumetric aerobiological survey of conidial fungi in the North-East Netherlands. I. Seasonal patterns and the influence of metereological variables. Allergy (1985) 0.94
A volumetric-aerobiologic study of seasonal fungus prevalence inside and outside dwellings of asthmatic patients living in northeast Netherlands. Ann Allergy (1984) 0.94
Invasive pulmonary aspergillosis in a non-immunosuppressed patient: successful management with systemic amphotericin and flucytosine and inhaled amphotericin. Thorax (1984) 0.93
Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy. Respiration (2010) 0.93
Allergen-avoidance measures in homes of house-dust-mite-allergic asthmatic patients: effects of acaricides and mattress encasings. Allergy (1997) 0.93
Occupational asthma in aluminium potroom workers related to pre-employment eosinophil count. Eur Respir J (1995) 0.93
Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis. J Allergy Clin Immunol (1997) 0.92
Prostaglandin E2 differentially modulates IL-5 gene expression in activated human T lymphocytes depending on the costimulatory signal. J Allergy Clin Immunol (1998) 0.91
Fluticasone propionate in children with moderate asthma. Am J Respir Crit Care Med (1996) 0.91
Atopy and bronchial hyperresponsiveness: exclusion of linkage to markers on chromosomes 11q and 6p. Clin Exp Allergy (1992) 0.91
Muscarinic receptors in human airway smooth muscle are coupled to phosphoinositide metabolism. Eur J Pharmacol (1989) 0.91
Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med (2000) 0.91
Hormones in the critically ill patient: to intervene or not to intervene? Intensive Care Med (2001) 0.91
Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. Intensive Care Med (2001) 0.90
Cultivation of fungi in synthetic and semi-synthetic liquid medium. II. Immunochemical properties of the antigenic and allergenic extracts. Allergy (1985) 0.89
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function. Eur Respir J (2006) 0.89
Antibodies against Aspergillus fumigatus. I. Standardization of the antigenic composition. Int Arch Allergy Appl Immunol (1980) 0.89
Plasma histamine concentrations and complement activation during house dust mite-provoked bronchial obstructive reactions. Clin Allergy (1983) 0.89
Early-onset phenytoin toxicity mimicking a renopulmonary syndrome. Eur Respir J (1998) 0.89
Peripheral blood T lymphocytes from asthmatic patients are primed for enhanced expression of interleukin (IL)-4 and IL-5 mRNA: associations with lung function and serum IgE. Clin Exp Allergy (1999) 0.88